Company Directory - Omeros Corporation
Company Details - Omeros Corporation
Omeros Corporation
WebsiteSeattle, United States
Omeros Corporation is a biopharmaceutical company focused on developing therapeutic products. The company is dedicated to the discovery, development, and commercialization of treatments addressing unmet medical needs, particularly in the areas of inflammation and other serious conditions.
CCI Score
CCI Score: Omeros Corporation
-38.14
0.03%
Latest Event
Omeros Corporation Lobbying Activity Profile
The OpenSecrets profile for Omeros Corporation details its engagement in federal lobbying activities. The profile, updated with data downloaded on February 19, 2025, indicates that the company actively utilizes multiple lobbying firms to influence policymaking and regulatory decisions.
Take Action
So what can you do? It's time to make tough choices. Where will you cast your vote?
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
TOADIE
Omeros Corporation is currently rated as a Toadie.
Latest Events
- FEB192025
The OpenSecrets profile for Omeros Corporation details its engagement in federal lobbying activities. The profile, updated with data downloaded on February 19, 2025, indicates that the company actively utilizes multiple lobbying firms to influence policymaking and regulatory decisions.
-40
Political Contributions and Lobbying Efforts
March 28
Omeros Corporation's active participation in federal lobbying, as evidenced by its detailed profile on OpenSecrets, raises concerns regarding its engagement in political influence. From an anti-fascist perspective, such lobbying activities can be seen as efforts to shape policy in ways that prioritize corporate interests over democratic accountability and worker rights.
- DEC312024
A new Lobbying Disclosure Act filing revealed that Omeros Corporation spent $45,000 on lobbying during Q4 2024. The filing disclosed efforts on issues including the 'No Pain' Act and the Hospital Outpatient Prospective Payment System, highlighting the company's political engagement.
-20
Political Contributions and Lobbying Efforts
March 28
The disclosed $45,000 lobbying expenditure indicates that Omeros Corporation is actively engaging in influencing public policy. From an anti-fascist perspective, such corporate political activities can contribute to the entrenchment of corporate influence over democratic processes, potentially marginalizing the interests of the broader public.
Lobbying Update: $45,000 of OMEROS CORPORATION lobbying was just disclosed
- DEC312024
OpenSecrets' profile reveals that Omeros Corporation spent $1,155,000 on lobbying during the 2024 cycle while contributing only $917, and that 7 out of 8 of its lobbyists had previous government experience, highlighting a concerning revolving door practice.
-70
Political Contributions and Lobbying Efforts
March 28
The profile shows significant lobbying spending relative to minimal campaign contributions, indicating a strategic focus on political influence that can undermine democratic accountability. This heavy spending on lobbying is viewed as contributing to a climate favorable to authoritarian interests.
-60
Executive Political Engagement
March 28
The fact that 7 out of 8 lobbyists employed by Omeros Corporation have previously held government positions suggests a strong revolving door dynamic, which raises concerns about undue influence and the potential for regulatory capture, aligning with authoritarian practices.
- DEC312024
In Q4 2024, Omeros Corporation disclosed $45,000 in lobbying expenses as part of a Lobbying Disclosure Act filing, which included efforts related to the 'No Pain' Act and the Hospital Outpatient Prospective Payment System.
-30
Political Contributions and Lobbying Efforts
March 28
The reported $45,000 in lobbying spending indicates that Omeros Corporation is engaging in political influence efforts. Such corporate lobbying can undermine democratic accountability by prioritizing business interests over public welfare, a behavior that is concerning from an anti-fascist perspective.
Lobbying Update: $45,000 of OMEROS CORPORATION lobbying was just disclosed
- JAN012023
Omeros Corporation spent $1,470,000 on lobbying activities in 2023, as reported by OpenSecrets. The expenditure is being scrutinized for its potential to unduly influence policy-making processes.
-50
Political Contributions and Lobbying Efforts
March 28
The company’s significant lobbying expenditure raises concerns about its role in potentially influencing public policy in ways that could undermine democratic accountability. Such spending is viewed negatively from an anti-fascist perspective, which emphasizes reducing corporate influence in politics.
Alternatives
Cranbury, United States
-15.14
Menlo Park, United States
-49.80
Belgium (Ghent), Belgium
79.03
Raleigh, USA
56.52
Basel, Switzerland
-19.75
Corporation
0.00
Corporation
0.00
Corporation
-52.53
Corporation
-26.78
New York, United States
30.41
Industries
- 325412
- Pharmaceutical Preparation Manufacturing
- 621511
- Medical Laboratories
- 541711
- Research and Development in Biotechnology